Veradigm Inc. (MDRX)
OTCMKTS
· Delayed Price · Currency is USD
4.300
0.00 (0.00%)
Jun 4, 2025, 10:25 AM EDT
Veradigm Revenue
In the year 2022, Veradigm had annual revenue of $588.02M with 1.83% growth. Veradigm had revenue of $151.92M in the quarter ending September 30, 2022, with 5.01% growth.
Revenue
588.02M
Revenue Growth
+1.83%
P/S Ratio
1.24
Revenue / Employee
240.01K
Employees
2,450
Market Cap
730.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 588.02M | 10.59M | 1.83% |
| Dec 31, 2021 | 577.43M | 21.31M | 3.83% |
| Dec 31, 2020 | 556.12M | -1.08B | -65.94% |
| Dec 31, 2019 | 1.63B | 14.77M | 0.91% |
| Dec 31, 2018 | 1.62B | 120.13M | 8.02% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 332.45M |
Veradigm News
- 16 days ago - Veradigm Recognized with KLAS 2025 Points of Light Award for Optimizing Value-Based Care - Business Wire
- 24 days ago - Veradigm Advances GLP-1 Real-World Evidence Generation with AI-Driven EHR Data Curation - Business Wire
- 2 months ago - Black Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025 - Business Wire
- 2 months ago - Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency - Business Wire
- 2 months ago - Veradigm Inc. (MDRX) Investor Update Call Transcript - Seeking Alpha
- 2 months ago - Veradigm Inc (MDRX) Reports Fiscal 2023 Revenue Between $620M-$625M and Net Income of ... - GuruFocus
- 2 months ago - Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership - Business Wire
- 2 months ago - Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025 - Business Wire